Reich, K; Burden, AD; Eaton, JN; Hawkins, NS; (2011) Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. The British journal of dermatology, 166. pp. 179-88. ISSN 0007-0963 DOI: https://doi.org/10.1111/j.1365-2133.2011.10583.x Full text not available from this repository.

Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: https://doi.org/10.1093/rheumatology/kem221 Full text not available from this repository.

Woolacott, N; Bravo Vergel, Y; Hawkins, N; Kainth, A; Khadjesari, Z; Misso, K; Light, K; Asseburg, C; Palmer, S; Claxton, K; +3 more... Bruce, I; Sculpher, M; Riemsma, R; (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 10. iii-iv, xiii-xvi, 1-239. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2534859

Woolacott, N; Hawkins, N; Mason, A; Al., E; (2006) Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health technology assessment (Winchester, England), 10. 1-233, i-iv. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta10460